TransMedics Group Statistics
Total Valuation
TMDX has a market cap or net worth of $4.50 billion. The enterprise value is $4.62 billion.
Market Cap | 4.50B |
Enterprise Value | 4.62B |
Important Dates
The last earnings date was Wednesday, July 30, 2025, after market close.
Earnings Date | Jul 30, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TMDX has 34.09 million shares outstanding. The number of shares has increased by 11.94% in one year.
Current Share Class | 34.09M |
Shares Outstanding | 34.09M |
Shares Change (YoY) | +11.94% |
Shares Change (QoQ) | +1.61% |
Owned by Insiders (%) | 3.29% |
Owned by Institutions (%) | 119.97% |
Float | 32.96M |
Valuation Ratios
The trailing PE ratio is 65.43 and the forward PE ratio is 57.56.
PE Ratio | 65.43 |
Forward PE | 57.56 |
PS Ratio | 8.37 |
Forward PS | 6.99 |
PB Ratio | 14.13 |
P/TBV Ratio | 15.15 |
P/FCF Ratio | 259.41 |
P/OCF Ratio | 39.05 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 46.06, with an EV/FCF ratio of 266.23.
EV / Earnings | 64.46 |
EV / Sales | 8.69 |
EV / EBITDA | 46.06 |
EV / EBIT | 60.33 |
EV / FCF | 266.23 |
Financial Position
The company has a current ratio of 9.86, with a Debt / Equity ratio of 1.63.
Current Ratio | 9.86 |
Quick Ratio | 8.93 |
Debt / Equity | 1.63 |
Debt / EBITDA | 4.85 |
Debt / FCF | 29.90 |
Interest Coverage | 5.42 |
Financial Efficiency
Return on equity (ROE) is 28.21% and return on invested capital (ROIC) is 6.20%.
Return on Equity (ROE) | 28.21% |
Return on Assets (ROA) | 5.80% |
Return on Invested Capital (ROIC) | 6.20% |
Return on Capital Employed (ROCE) | 9.18% |
Revenue Per Employee | $729,797 |
Profits Per Employee | $98,437 |
Employee Count | 728 |
Asset Turnover | 0.64 |
Inventory Turnover | 4.64 |
Taxes
In the past 12 months, TMDX has paid $2.43 million in taxes.
Income Tax | 2.43M |
Effective Tax Rate | 3.28% |
Stock Price Statistics
The stock price has decreased by -19.01% in the last 52 weeks. The beta is 2.08, so TMDX's price volatility has been higher than the market average.
Beta (5Y) | 2.08 |
52-Week Price Change | -19.01% |
50-Day Moving Average | 124.13 |
200-Day Moving Average | 91.39 |
Relative Strength Index (RSI) | 61.77 |
Average Volume (20 Days) | 1,392,687 |
Short Selling Information
The latest short interest is 7.67 million, so 22.50% of the outstanding shares have been sold short.
Short Interest | 7.67M |
Short Previous Month | 8.00M |
Short % of Shares Out | 22.50% |
Short % of Float | 23.27% |
Short Ratio (days to cover) | 6.69 |
Income Statement
In the last 12 months, TMDX had revenue of $531.29 million and earned $71.66 million in profits. Earnings per share was $2.02.
Revenue | 531.29M |
Gross Profit | 317.68M |
Operating Income | 76.58M |
Pretax Income | 1.48M |
Net Income | 71.66M |
EBITDA | 100.30M |
EBIT | 76.58M |
Earnings Per Share (EPS) | $2.02 |
Balance Sheet
The company has $400.58 million in cash and $518.82 million in debt, giving a net cash position of -$118.25 million or -$3.47 per share.
Cash & Cash Equivalents | 400.58M |
Total Debt | 518.82M |
Net Cash | -118.25M |
Net Cash Per Share | -$3.47 |
Equity (Book Value) | 318.10M |
Book Value Per Share | 9.34 |
Working Capital | 501.51M |
Cash Flow
In the last 12 months, operating cash flow was $115.27 million and capital expenditures -$97.92 million, giving a free cash flow of $17.35 million.
Operating Cash Flow | 115.27M |
Capital Expenditures | -97.92M |
Free Cash Flow | 17.35M |
FCF Per Share | $0.51 |
Margins
Gross margin is 59.79%, with operating and profit margins of 14.41% and 13.49%.
Gross Margin | 59.79% |
Operating Margin | 14.41% |
Pretax Margin | 13.95% |
Profit Margin | 13.49% |
EBITDA Margin | 18.88% |
EBIT Margin | 14.41% |
FCF Margin | 3.27% |
Dividends & Yields
TMDX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -11.94% |
Shareholder Yield | -11.94% |
Earnings Yield | 1.59% |
FCF Yield | 0.39% |
Analyst Forecast
The average price target for TMDX is $129.11, which is -2.22% lower than the current price. The consensus rating is "Buy".
Price Target | $129.11 |
Price Target Difference | -2.22% |
Analyst Consensus | Buy |
Analyst Count | 10 |
Revenue Growth Forecast (5Y) | 20.93% |
EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
TMDX has an Altman Z-Score of 4.67 and a Piotroski F-Score of 6.
Altman Z-Score | 4.67 |
Piotroski F-Score | 6 |